When to Skip Your Allergy Shot: The Complete Decision Checklist

Missing an allergy shot during the build-up phase typically requires your allergist to reduce your next dose to the previously tolerated level before re-escalating. The specific dose reduction depends on how long you missed: gaps of 1-7 days may require only a small step back; gaps of more than 7 days usually mean returning to the last confirmed safe dose. Gaps of more than 3-4 weeks may require restarting the build-up phase from a lower starting dose. This is why communication with your allergist is essential — call ahead when you need to skip so they can plan the appropriate dose adjustment for your next visit. Repeated missed appointments during build-up can significantly delay reaching the therapeutic maintenance dose and reduce the overall effectiveness of treatment. Each gap-related dose reduction also extends the time you spend in the build-up phase.

Whether you should get an allergy shot with a cold depends on whether you have a fever and whether your breathing is affected. A mild cold with nasal symptoms but no fever and no respiratory involvement is often acceptable — many allergists proceed with injections in this scenario, though they may monitor more closely. However, if your cold includes fever above 100.5°F, significant respiratory symptoms, wheezing, or chest tightness, you should skip the appointment. The fever threshold is absolute: fever signals active immune system engagement from infection that can increase systemic reaction risk during immunotherapy. The safest approach is always to call your allergist's advice line before your appointment when you are sick, rather than making the skip decision independently. This allows your clinical team to assess the specific situation and advise accordingly.

No — seasonal allergy symptoms are not a reason to skip your allergy shot. In fact, continuing immunotherapy during your worst symptomatic periods is an important part of how the treatment works. Your immune system is being actively exposed and retrained during periods of natural allergen exposure, and skipping during high-symptom seasons counteracts this therapeutic process. AAAAI patient education explicitly states that allergy flares are not a skip indication. You should always disclose your current symptom severity to the clinic nurse before your injection — they may adjust the dose or monitor more closely — but the standard recommendation is to proceed. Many patients incorrectly assume that feeling unwell from allergies means they should skip. Unless you have fever, active wheezing, or another clinical contraindication, attend your scheduled appointment.

Whether you can receive an allergy shot shortly after another vaccine depends on the type of vaccine. Inactivated vaccines (flu shots, COVID vaccines, Tdap, hepatitis vaccines) generally do not require a waiting period before allergy shots — most allergists proceed without delay. Live virus vaccines (MMR, varicella, yellow fever, live attenuated influenza spray) are more complex. Many allergists recommend waiting 7-14 days after a live virus vaccine before the next allergy shot because live vaccines cause transient immune activation that may compound with the allergen injection response. Some allergists prefer separating allergy shots and any vaccination by at least 24-48 hours to avoid confusing injection site reactions. The safest approach is to tell your allergist at any visit that you have recently received a vaccination, and follow their specific guidance for timing. Call your allergist's advice line if you receive a vaccine close to a scheduled allergy shot appointment.

If you are taking non-cardioselective beta-blockers, allergy shots are contraindicated and you should not receive them until you discuss this with both your allergist and the prescribing physician. Beta-blockers work by blocking beta-adrenergic receptors — the same receptors that epinephrine acts on during anaphylaxis treatment. If you experience a systemic reaction while on beta-blockers, the standard epinephrine dose may be insufficient to reverse the reaction effectively. This is an absolute safety contraindication documented in AAAAI practice parameters. Cardioselective beta-blockers (targeting beta-1 receptors primarily) carry less, but not zero, risk — some allergists will proceed with heightened caution for patients on low doses of cardioselective agents, while others maintain the contraindication. You must discuss this with your allergist before starting immunotherapy, and before any change in your cardiac medications during treatment.

The permissible gap between allergy shots depends on which treatment phase you are in. During the build-up phase: gaps of up to 7 days typically allow continuation at the same dose; gaps of 7-14 days usually require dose reduction to the previously tolerated level; gaps beyond 3-4 weeks may require a more significant reduction or restart. During the maintenance phase: gaps of 2-4 weeks are generally tolerable without dose adjustment; gaps of 4-8 weeks usually require some dose reduction at the next visit; gaps beyond 8-12 weeks may require restarting the maintenance protocol at a lower dose. Individual protocols vary by allergist and by how you tolerated previous doses. These guidelines are based on AAAAI dose adjustment recommendations, but your specific protocol should be confirmed with your treating allergist, who knows your complete reaction history and will individualize the dose adjustment decision.